United Therapeutics Prepares for TYVASO Expansion After $833 Million Quarter
SGIOY or UTHR: Which Is the Better Value Stock Right Now?
Here's How Much $100 Invested In United Therapeutics 15 Years Ago Would Be Worth Today
United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences
HC Wainwright & Co. Assumes United Therapeutics at Buy, Announces Price Target of $660
The 5 most interesting analyst questions from United Therapeutics’s Q3 2026 earnings call
United Therapeutics (UTHR) Stock May Be Undervalued After $2B Buyback Plan
TD Cowen Maintains Buy on United Therapeutics, Raises Price Target to $700
RBC Capital Maintains Outperform on United Therapeutics, Raises Price Target to $725
Wells Fargo Maintains Overweight on United Therapeutics, Raises Price Target to $703
Should Record Revenue Require Action From United Therapeutics Stock Investors?
What Is Drawing Attention To United Therapeutics (UTHR) Today?
United Therapeutics Corporation Q3 2026 Earnings Call Summary
What United Therapeutics (UTHR) Said on Its Q3 Earnings Call
United Therapeutics Corp (UTHR) Q3 2026 Earnings Call Highlights: Record Revenue of $833 ...
United Therapeutics (UTHR) Q3 2026 Earnings Call Transcript
BTIG Maintains Buy on United Therapeutics, Raises Price Target to $768
United Therapeutics Corporation (UTHR) Q3 2026 Earnings Call Transcript
United Therapeutics Corporation 2026 Q3 - Results - Earnings Call Presentation
United Therapeutics (UTHR) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.